Erratum: Actin-binding protein alpha-actinin 4 (ACTN4) is a transcriptional co-activator of RelA/p65 sub-unit of NF-kB
Oncotarget
.
2018 Sep 28;9(76):34450.
doi: 10.18632/oncotarget.26206.
Authors
Vasilisa Aksenova
1
2
,
Lidia Turoverova
1
,
Mikhail Khotin
1
,
Karl-Eric Magnusson
3
,
Eugene Tulchinsky
4
,
Gerry Melino
2
5
,
George P Pinaev
1
,
Nickolai Barlev
1
2
6
,
Dmitri Tentler
1
2
Affiliations
1
Institute of Cytology, Russian Academy of Sciences, Tikhoretsky av., 4, St. Petersburg, Russia.
2
Laboratory of Molecular Pharmacology, Saint-Petersburg Technological Institute, 26 Moskovsky Prospect, St. Petersburg, Russia.
3
Division of Medical Microbiology, Department of Clinical and Experimental Medicine, Linköping University, SE-581 85 Linköping, Sweden.
4
Department of Cancer Studies and Molecular Medicine, University of Leicester, RKCSB, LRI, Leicester, UK.
5
MRC Toxicology Unit, Leicester, UK.
6
Department of Biochemistry, University of Leicester, Lancaster Road, Leicester, UK.
PMID:
30344954
PMCID:
PMC6188133
DOI:
10.18632/oncotarget.26206
Abstract
[This corrects the article DOI: 10.18632/oncotarget.901.].
Publication types
Published Erratum
Grants and funding
MC_U132670600/MRC_/Medical Research Council/United Kingdom
MC_UU_00025/2/MRC_/Medical Research Council/United Kingdom